Member Info for HarChris

Triumph, you're right. Worst case scenario is that novacyt's products fall out of favour and the company is left with around £300m cash to go in new directions (making the current mcap of £700m still fairly low).

The best case scenario is novacyt's instruments are embedded across the nhs with rolling government contracts into the long term - making the current mcap of £700m an absolute steal).

My money is staying put.

It really depends how much of the market boohoo corner this christmas/winter. Their online presence makes them well placed to grow extraordinarily over the next six months and so if a) revenue/profits continue to grow close to 50% yoy and b) they can avoid further negative publicity then they will reach £5 within the next six months...

The fact you get so riled by it rather than just ignore it says more about you than SH3. If you don't like his comments it really is so so easy to filter or just look past them to the next comment. The rest of us can do it, why can't you?

I don't know if the fact that the fund is US based is relevant but it is the increasing size of the US revenues that draws me in here. The US market is incomparable to the UK and if boohoo really crack it then this share price will explode over the next twelve months.

I topped up heavily earlier and am now going to stick it out long term rather than look for a satisfactory exit point...

I was like you a few months ago but now I'm chilled. got more money in here than I can really afford to lose but I'm trusting the company will come good 12 months down the road. Besides that I'm switching off.

What I've noticed with boo is it suddenly catches a break when you least expect it. If it doesn't happen today I'm almost certain it will be at some point this week. 300p by end of the week is well possible...

Isn't that small test in the picture the antibody test?

The issue I have with your post triumph1 is that there really hasn't been much negativity on here following the huge drop over the past 24 hours. In fact everyone on here appears to be positive still and is looking at the bigger picture with numerous comments along the lines of 'I've lost £20k in the last day and I'm not worried one iota'

If this board turns into a moan fest then I'll agree with you.

Voltaire they were buying on the 22nd October (and possibly before). It wasn't likely to have an immediate effect but in the circumstances it's great to see a positive holding rns rather than find a fund is dumping. I topped up at 273p off of it anyhow.

I'm sick of hearing this stupid view that holding shares is greedy. We believe in the company and it doesn't matter how much it rises, many of us are in this for the long haul. Yes at some point that rise was going to come to an end but we had no idea when exactly that was going to be - it could have risen all the way up to £15 before dropping back to £13 and we'd all be laughing.

Sod off with your hindsight.

If you're talking about the holding rns it's really very simple. Previously they held no shares (or at least less than 3%) and now they hold 5.04%. They have been buying...

You are wrong, thankfully.

Slipperz if you're right then that drop last week was one of the biggest overreactions I've ever seen investing! From 315p at cob on the Friday to a low of 215p on the Tuesday morning. Bought two more lots in the 250-275p range but missed out on the low 200s.

Sure you could tyla but at 1 share for every 37 it wouldn't have made too much of a difference.

My initial reaction when the price crashed earlier was 'you idiot, you were about to sell some and then didn't!'

Then I remember that I nearly sold some at £7, at £8, at £9, at £10 and at £11.

No it won't necessarily. It already is looking 12-18-24 months ahead and is predicting the demand for pcr testing to massively reduce - otherwise why would we be valued at £700m when we're probably already making more money than that and have zero debt?

Obviously the later a successful vaccine is ready the higher the valuation and potential profit for novacyt... but it will be at least six months AFTER a vaccine that we'll have any idea if a vaccine has been effective. That takes us to the middle part of next year at the absolute earliest.

The first mover advantage for boohoo really isn't something to be sniffed at, it's a crucially important point. The move to online is going to be dramatic and significant and it won't be easy for retail giants without an online presence to make a smooth transition.

Not only that companies are torn between committing big resource to online or holding off to see how the pandemic plays out over the next 3-6 months. Expect many big names to fall and boohoo to swoop some of them up...

We all know that if demand for testing continues well into the 2020s then you can add a zero to the current share price. Nothing in life is a dead cert but the risk/reward profile even at £12 a share is exceptional.

Managed an extra 2000 shares .2p above the placing price. It felt like a steal to get the price IIs snapped up £80m worth at.

Just looking for example at yourgene health today... revenues for H1 were £8.2m, mcap £135m.

Let's be generous and call full year £20m revenue. We're looking at potentially 25-30 times the revenue whilst mcap is about 6 times greater. Very simple point being made but highlights just what a position ncyt have engineered in this market.

No other company in the sector comes close.